Statistics
Publications
22
Citations
2.8K
H-Index
21
Active since
1991
Claus Spitzfaden is an author at GlaxoSmithKline (United Kingdom) specializing in biochemistry, structural biology, and life sciences.
Publications per year
1991–2022
22
22
Type IIA topoisomerase inhibition by a new class of antibacterial agents
B.D. Bax, Pan F. Chan, Drake S. Eggleston et al. · Nature · 2010 · 842 citations
Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.
David Howlett, Amanda Perry, Fiona GODFREY et al. · PubMed · 1999 · 180 citations · Full text
Pharmacy, Biochemistry, Pharmacology +15
1–5 of 22